There is some experimental work using chimeric antigen receptor engineered T cells (CAR-T cells) for therapy to target cancer stem cells. What CD receptor is being considered an attractive therapeutic target for such a novel approach?
A. CD19
B. CD22
C. CD55
D. CD133
